Ngilirabanga, J.B.Samsodien, H.2021-09-072021-09-072020Ngilirabanga, Jean & Samsodien, Halima. (2021). Pharmaceutical co‐crystal: An alternative strategy for enhanced physicochemical properties and drug synergy. Nano Select. 2. 10.1002/nano.202000201.2688-401110.1002/nano.202000201http://hdl.handle.net/10566/6623A growing number of co-crystals in the literature are proof of how significant the co-crystallization concept has become. Co-crystallization enhances physicochemical properties through the formation of intermolecular interactions between a drug and a co-former. A co-crystal is a single crystalline material consisting of at least two molecular components solid at room temperature and present in a definite stoichiometric ratio. Pharmaceutical co-crystals consist of the active pharmaceutical ingredient and the co-former selected from generally regarded as safe (GRAS) list of the United State Food and Drug Administration.enCo-crystal developmentCo-crystallizationDesignPharmaceutical co-crystalsSynergistic co-crystalsArticle